Exclusive Global License Agreement Sample Contracts

10770 Wateridge Circle, Suite 120 San Diego, CA 92120
Exclusive Global License Agreement • May 9th, 2024
Contract
Exclusive Global License Agreement • December 10th, 2024

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions